Human protein tyrosine phosphatase inhibitors and methods of use

Details for Australian Patent Application No. 2012200253 (hide)

Owner Warner Chilcott, LLC

Inventors Gray, Jeffrey Lyle; Maier, Mathew Brian; Clark, Cynthia Monesa; Amarasinghe, Kande; Nichols, Ryan

Agent Griffith Hack

Pub. Number AU-B-2012200253

Parent 2007265455

Filing date 16 January 2012

Wipo publication date 16 February 2012

Acceptance publication date 5 July 2012

International Classifications

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/425 - Thiazoles

A61P 35/00 Antineoplastic agents

Event Publications

2 February 2012 Complete Application Filed

16 February 2012 Application Open to Public Inspection

  Published as AU-B-2012200253

5 July 2012 Application Accepted

  Published as AU-B-2012200253

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012200254-Process for the production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-oxo-2-substituted-2,3-dihydro1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process

2012200252-Hybrid power control system